4//SEC Filing
CATALYST PHARMACEUTICALS, INC. 4
Accession 0001161697-15-000476
$CPRXCIK 0001369568operating
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 11:26 AM ET
Size
7.1 KB
Accession
0001161697-15-000476
Insider Transaction Report
Form 4
Winship M Douglas
V.P. of Regulatory Operations
Transactions
- Exercise/Conversion
Options to purchase common stock
2015-11-04−60,000→ 237,500 totalExercise: $1.09Exp: 2015-11-05→ Common Stock (60,000 underlying) - Exercise/Conversion
Common stock, par value $0.001 per share
2015-11-04$1.09/sh−60,000$65,400→ 134,131 total
Footnotes (1)
- [F1]The option was granted on November 5, 2010 and vested in three equal annual installments.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369568
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 11:26 AM ET
- Size
- 7.1 KB